Loading…
Design and synthesis of novel glycyrrhetinic acid-triazole derivatives that exert anti-plasmodial activity inducing mitochondrial-dependent apoptosis in
Malaria is an enormous threat to public health due to the emergence of Plasmodium falciparum resistance to widely used anti-malarials, such as chloroquine. Additionally, the commercially used antimalarial drugs affected by this drug resistance are associated with side effects; thus, there is a need...
Saved in:
Published in: | New journal of chemistry 2023-04, Vol.47 (14), p.6967-6982 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Malaria is an enormous threat to public health due to the emergence of
Plasmodium falciparum
resistance to widely used anti-malarials, such as chloroquine. Additionally, the commercially used antimalarial drugs affected by this drug resistance are associated with side effects; thus, there is a need to identify a template with fewer side effects and improved efficacy. Therefore, in the present study, a click chemistry approach was used to design and synthesize glycyrrhetinic acid-triazole derivatives and determine their antiplasmodial activity against a chloroquine-sensitive (NF-54) strain of
P. falciparum
. Among the sixteen glycyrrhetinic acid derivatives, compound-
17
was found to be the most active against the chloroquine-sensitive (NF-54) strain of
P. falciparum
with an IC50 of 0.47 ± 0.04 μM. However, compound-
17
showed no effect on heme polymerization, the most common target in malaria parasites. The increased ROS levels, decrease in the GSH/GSSG ratio, metabolic activity, mitochondrial potential, further increase in the caspase-3 activity, and DNA damage are possibly responsible for the apoptotic death of
P. falciparum
. Interestingly, compound-
17
showed significant chemo-suppression of parasitemia and hemoglobin content, reduced hepatic damage, decreased production of inflammatory cytokines, and decreased plasmodial infection in mice models.
In vitro
cytotoxicity/hemolysis assay suggests that compound-
17
is safe to explore its therapeutic properties further. Based on these results, the synthesized compound-
17
appears to be a viable template derivative, able to overcome the problem of drug-resistance and enhance anti-plasmodial activity against
P. falciparum
, making it an attractive anti-malarial agent.
Malaria is an enormous threat to public health due to the emergence of
Plasmodium falciparum
resistance to widely used anti-malarials, such as chloroquine. |
---|---|
ISSN: | 1144-0546 1369-9261 |
DOI: | 10.1039/d2nj05302k |